These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22858098)

  • 1. Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screening.
    Geldenhuys WJ; Talasila PK; Sadana P
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5675-8. PubMed ID: 22858098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.
    Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold.
    Ortuso F; Amato R; Artese A; D'antona L; Costa G; Talarico C; Gigliotti F; Bianco C; Trapasso F; Schenone S; Musumeci F; Botta L; Perrotti N; Alcaro S
    J Chem Inf Model; 2014 Jul; 54(7):1828-32. PubMed ID: 24896223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Kinetic Characterization of Serum- and Glucocorticoid-Regulated Kinase Inhibitors Using a Fluorescence Polarization-Based Assay.
    Kim J; Kim D; Jung H; Lee J; Hong VS
    SLAS Discov; 2021 Jun; 26(5):655-662. PubMed ID: 33783250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors.
    Hammond M; Washburn DG; Hoang HT; Manns S; Frazee JS; Nakamura H; Patterson JR; Trizna W; Wu C; Azzarano LM; Nagilla R; Nord M; Trejo R; Head MS; Zhao B; Smallwood AM; Hightower K; Laping NJ; Schnackenberg CG; Thompson SK
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4441-5. PubMed ID: 19497745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.
    Gong GQ; Wang K; Dai XC; Zhou Y; Basnet R; Chen Y; Yang DH; Lee WJ; Buchanan CM; Flanagan JU; Shepherd PR; Chen Y; Wang MW
    Acta Pharmacol Sin; 2018 Dec; 39(12):1902-1912. PubMed ID: 30038340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of SEK1 signaling by serum- and glucocorticoid-inducible protein kinase 1.
    Kim MJ; Chae JS; Kim KJ; Hwang SG; Yoon KW; Kim EK; Yun HJ; Cho JH; Kim J; Kim BW; Kim HC; Kang SS; Lang F; Cho SG; Choi EJ
    EMBO J; 2007 Jul; 26(13):3075-85. PubMed ID: 17568772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational insights into the active structure of SGK1 and its implication for ligand design.
    Akhoon BA; Gandhi NS; Pandey R
    Biochimie; 2019 Oct; 165():57-66. PubMed ID: 31302161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating ligand-based and protein-centric virtual screening of kinase inhibitors using ensembles of multiple protein kinase genes and conformations.
    Dixit A; Verkhivker GM
    J Chem Inf Model; 2012 Oct; 52(10):2501-15. PubMed ID: 22992037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover.
    Engelsberg A; Kobelt F; Kuhl D
    Biochem J; 2006 Oct; 399(1):69-76. PubMed ID: 16776652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterocyclic indazole derivatives as SGK1 inhibitors, WO2008138448.
    Lang F; Görlach A
    Expert Opin Ther Pat; 2010 Jan; 20(1):129-35. PubMed ID: 20021289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening.
    Lu S; Sun SL; Liu HC; Chen YD; Yuan HL; Gao YP; Yang P; Lu T
    Chem Biol Drug Des; 2012 Aug; 80(2):328-39. PubMed ID: 22583481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
    Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
    Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation.
    D'Antona L; Amato R; Talarico C; Ortuso F; Menniti M; Dattilo V; Iuliano R; Gigliotti F; Artese A; Costa G; Schenone S; Musumeci F; Abbruzzese C; Botta L; Trapasso F; Alcaro S; Paggi MG; Perrotti N
    Cell Physiol Biochem; 2015; 35(5):2006-18. PubMed ID: 25871776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.
    Schoene J; Gazzi T; Lindemann P; Christmann M; Volkamer A; Nazaré M
    ChemMedChem; 2019 Aug; 14(16):1514-1527. PubMed ID: 31264364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
    Ren JX; Li LL; Zou J; Yang L; Yang JL; Yang SY
    Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.
    Han W; Ding Y; Xu Y; Pfister K; Zhu S; Warne B; Doyle M; Aikawa M; Amiri P; Appleton B; Stuart DD; Fanidi A; Shafer CM
    J Med Chem; 2016 Apr; 59(7):3034-45. PubMed ID: 27002243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMD638683, a novel SGK inhibitor with antihypertensive potency.
    Ackermann TF; Boini KM; Beier N; Scholz W; Fuchss T; Lang F
    Cell Physiol Biochem; 2011; 28(1):137-46. PubMed ID: 21865856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening.
    Mortier J; Masereel B; Remouchamps C; Ganeff C; Piette J; Frederick R
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4515-20. PubMed ID: 20580552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.